A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Clinical trial NCT06316531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06316531
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-08
- Primary completion
- 2026-10-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.